Amylyx Pharmaceuticals shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.7M | 388k | 14.72 |
| 2023-09-30 | $6.7M | 366k | 18.31 |
| 2023-06-30 | $7.0M | 326k | 21.57 |
| 2023-03-31 | $9.4M | 320k | 29.34 |
| 2022-12-31 | $12M | 318k | 36.95 |
| 2022-09-30 | $6.8M | 241k | 28.15 |
| 2022-06-30 | $1.4M | 70k | 19.27 |
| 2022-03-31 | $939k | 73k | 12.86 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management